SCHEMBL10069153

SCHEMBL10069153

Cc1ccc(N=O)cc1Nc1nc(-c2cccnc2)cs1

nearest known ligand 0.81

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.81
MEN1 O00255 5/20 0.74
KMT2A Q03164 5/20 0.74
RAB9A P51151 7/20 0.71
NPC1 O15118 6/20 0.71
POLB P06746 2/20 0.71
TDP1 Q9NUW8 1/20 0.71
CASP3 P42574 1/20 0.65
SENP8 Q96LD8 1/20 0.65
SENP7 Q9BQF6 1/20 0.65
SENP6 Q9GZR1 1/20 0.65
KIT P10721 7/20 0.58
ALDH1A1 P00352 1/20 0.58
NFKB1 P19838 1/20 0.58
NFKB2 Q00653 1/20 0.58
RELA Q04206 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
MAPK1 P28482 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26208469 0.90 GAA (1.00) GAAMEN1KMT2ARAB9ANPC1
SCHEMBL8741770 0.86 MEN1 (0.76) GAAMEN1KMT2ARAB9ANPC1
SCHEMBL1096303 0.85 GAA (0.79) GAAMEN1KMT2ARAB9ANPC1
SCHEMBL2705354 0.85 GAA (0.79) GAAMEN1KMT2ARAB9ANPC1
SCHEMBL31290952 0.85 GAA (0.79) GAAMEN1KMT2ARAB9ANPC1
SCHEMBL4376632 0.82 GAA (0.74) GAAMEN1KMT2ARAB9ANPC1
SCHEMBL16365487 0.81 GAA (0.73) GAAMEN1KMT2ARAB9ANPC1
SCHEMBL1097467 0.81 GAA (0.72) GAAMEN1KMT2ARAB9ANPC1
SCHEMBL30672478 0.81 GAA (0.72) GAAMEN1KMT2ARAB9ANPC1
SCHEMBL4834856 0.81 GAA (0.72) GAAMEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120196871-A1 PROCESS FOR THE SYNTHESIS OF 2-AMINOTHIAZOLE COMPOUNDS AS KINASE INHIBITORS AB SCIENCE (FR) 2012-08-02 US disclosed
US-8153792-B2 Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors AB SCIENCE (FR) 2012-04-10 US disclosed
US-20110065734-A1 NOVEL BIFUNCTIONAL COMPOUNDS WHICH INHIBIT PROTEIN KINASES AND HISTONE DEACETYLASES 4SC AG (DE) 2011-03-17 US disclosed
US-20100121063-A1 PROCESS FOR THE SYNTHESIS OF 2-AMINOTHIAZOLE COMPOUNDS AS KINASE INHIBITORS AB SCIENCE (FR) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065734-A1 NOVEL BIFUNCTIONAL COMPOUNDS WHICH INHIBIT PROTEIN KINASES AND HISTONE DEACETYLASES HDAC1, HDAC11, MAP2K2 GAA 846/4885MEN1 2479/4885KMT2A 318/4885
US-20100121063-A1 PROCESS FOR THE SYNTHESIS OF 2-AMINOTHIAZOLE COMPOUNDS AS KINASE INHIBITORS ABL1, ABL2, KIT GAA 1899/4885MEN1 2544/4885KMT2A 291/4885
US-20120196871-A1 PROCESS FOR THE SYNTHESIS OF 2-AMINOTHIAZOLE COMPOUNDS AS KINASE INHIBITORS ABL1, ABL2, ALK GAA 1823/4885MEN1 2595/4885KMT2A 268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.